PAA have claimed to have the way to manufacture the tablets since late 2018, other companies have been able to develop, get approval, produce and get to market covid 19 vaccine in just over 12 months.
So why has not PAA at least moved forward, first we had to wait on the canine outcome before we moved on to human cancer trials, now we have to wait for MND trials.
Yet the main play here is still cancer yet human / canine cancers.
Monopantel was proven safe in 2016 / 2017 and still no further in humans been done since
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity, page-227
-
- There are more pages in this discussion • 506 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $99.76M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 20.5¢ | 20.0¢ | $86.39K | 425.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 245685 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 204582 | 4 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |